Status:
COMPLETED
Impact of Pitavastatin in Hypercholesterolemic Patients With Metabolic Syndrome
Lead Sponsor:
Aichi Gakuin University
Conditions:
Metabolic Syndrome
Oxidative Stress
Eligibility:
All Genders
20+ years
Phase:
PHASE4
Brief Summary
The purpose of this study is to evaluate anti-oxidative and anti-inflammatory effects of pitavastatin in hypercholesterolemic patients with the metabolic syndrome.
Detailed Description
The metabolic syndrome is defined as a cluster of cardiovascular risk factors including visceral obesity, dyslipidemia, elevated blood pressure and impaired glucose tolerance. Recently, it has been de...
Eligibility Criteria
Inclusion
- Hypercholesterolemic patients
Exclusion
- Patients receiving lipid-lowering agents
- Familial hypercholesterolemia
- Renal disease
- Diseases of liver, gallbladder and bile ducts
- Pregnant women
Key Trial Info
Start Date :
April 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2008
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00444717
Start Date
April 1 2007
End Date
September 1 2008
Last Update
July 13 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tatsuaki Matsubara
Nagoya, Aichi-ken, Japan, 464-8651